FOOTnotes from the ED: Sole-Crushing DKA, Decompensation and Diabetic Feet Date: Mon, Apr 28th, 2025 Time: 6:00 pm - 8:00 pm Location: Online
Speaker:
Saumil Parikh, MD Disclosures: None
Objectives:
Target Audience: podiatrists, residents, students
> Recognize the clinical presentation and diagnostic criteria for diabetic ketoacidosis (DKA) in the emergency department setting, including relevant laboratory findings and physical exam features.
> Describe the pathophysiology of DKA and its implications for systemic and end-organ function, with emphasis on how this may impact foot health and wound healing.
> Outline the emergency management of DKA, including fluid resuscitation, insulin therapy, electrolyte correction, and criteria for ICU admission.
> Discuss the role of the emergency physician in identifying and managing DKA complications that are particularly relevant to podiatric patients, such as infection, sepsis, and limb ischemia.
> Explain the podiatric implications of DKA, including its role as a potential marker for poor diabetes control and increased risk of foot ulcers, osteomyelitis and lower extremity amputation.
Approval for Podiatric Medical Education
NewYork Presbyterian/Queens is approved by the Council on Podiatric Medical Education as a provider of continuing medical education in podiatric medicine. NewYork Presbyterian/Queens has approved this activity for a maximum of 2.0 continuing education contact hours.
Disclosure Statement
The Medical Society of The State of New York relies upon planners and faculty participants in its CME activities to provide educational information that is objective and free of bias. In this spirit and in accordance with the guidelines of MSSNY, CPME and the ACCME, all speakers and planners for CME activities must disclose any relevant financial relationships with
commercial interests whose products, devices or services may be discussed in the content of a CME activity, that might be perceived as a real or apparent conflict of interest. Any discussion of investigational or unlabeled uses of a product will be identified.